Accessibility Menu
 
Lattice Biologics logo

Lattice Biologics

(OTC) LBLTF

Current Price$0.00
Market CapN/A
Since IPO (2016)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Lattice Biologics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.56M

Net Income (TTM)

$922.85K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

10.65 (High)

Price

$0.00

Volume

3,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

LBLTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lattice Biologics

Industry

Biotechnology

Headquarters

Belgrade, MT 59714, US

LBLTF Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

-14%

Net Income Margin

-60%

Return on Equity

0%

Return on Capital

7%

Return on Assets

-49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

3.00K

Avg. Volume

209.677

Financials (TTM)

Gross Profit

$1.02M

Operating Income

$336.00K

EBITDA

$58.30K

Operating Cash Flow

$536.15K

Capital Expenditure

$592.08K

Free Cash Flow

$55.93K

Cash & ST Invst.

$57.22K

Total Debt

$3.14M

Lattice Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$25.85K

+91.9%

EBITDA

$43.06K

+124.1%

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Net Cash

$0.00

+100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-49.14%

N/A

Return on Invested Capital

6.98%

N/A

Free Cash Flow

$2.13K

+102.3%

Operating Cash Flow

$2.13K

+102.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VRNOFVerano Holdings Corp.
$1.30+8.33%
CLVSFCellaVision AB (publ)
$13.49+0.00%
CALZFPolyNovo Limited
$0.86+3.76%
AVNBFAvon Technologies Plc
$21.28-7.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$10.62-0.05%
FFord Motor Company
$13.40-0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.06-0.10%
TQQQProShares Trust - ProShares UltraPro Qqq
$75.34-0.05%

Questions About LBLTF

What is the current price of Lattice Biologics?

Lattice Biologics is trading at N/A per share.

What is the 52-week range for Lattice Biologics?

Over the past 52 weeks, Lattice Biologics has traded between N/A and N/A.

How much debt does Lattice Biologics have?

Lattice Biologics total debt is unavailable.

How much cash does Lattice Biologics have on hand?

Lattice Biologics does not have cash on hand data available.

What is Lattice Biologics’s dividend yield?

Lattice Biologics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.